US and UK securities expert Claire Keast-Butler heads up the team at Cooley (UK) LLP following the April 2024 departure of David Boles and is particularly well-versed in handling IPOs, public M&A, and dual listings for UK clients. The practice maintains close relationships with a host of clients in the life sciences sector, who routinely instruct it to act on primary and follow-on fundraises with both debt and equity elements. Simon Amies, who joined the team from Covington & Burling LLP in May 2023, is a key contact for this line of work.
L’éditorial du Legal 500
- Profil
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Well-versed in US securities law and practical advice.’
'Sam Meiklejohn is an up and coming talent; responsive and stepping up to lead transactions.'
'A good, commercial and pragmatic team.'
Clients clés
- Silence Therapeutics
- Redx Pharma
- WeTransfer
- Super Group Limited
- Alvotech
- Biote
- Immunocore
- Renalytix
- Verona Pharma
- Wizz Air
Points forts
- Advised Wizz Air on its Class 1 transaction relating to the purchase of a 75 aircraft.
- Advised Bicycle on a $230 million follow on offering of ADS and non-voting ordinary shares.
- Advised Allergy Therapeutics, a UK AIM-listed commercial biotechnology company specialising in allergy vaccines, on its £40.75m secured bridge debt financing and subsequent £40.75m equity financing as well as on a mandatory cash offer by ZQ Capital, valuing the company at £48 million as required under the Takeover Code as a result of completion of the equity financing.
Avocats
Les grands avocats du marché
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Responsable de la pratique
Claire Keast-Butler
Autres avocats clés
Simon Amies; Sam Meikeljohn